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Abstract
Bacillus amyloliquefaciens H57 is a bacterium isolated from lucerne for its ability to prevent feed spoilage. Further
interest developed when ruminants fed with H57-inoculated hay showed increased weight gain and nitrogen
retention relative to controls, suggesting a probiotic effect. The near complete genome of H57 is ~3.96 Mb
comprising 16 contigs. Within the genome there are 3,836 protein coding genes, an estimated sixteen rRNA genes
and 69 tRNA genes. H57 has the potential to synthesise four different lipopeptides and four polyketide compounds,
which are known antimicrobials. This antimicrobial capacity may facilitate the observed probiotic effect.
Keywords: Bacillus amyloliquefaciens, Probiotic, Antimicrobials, Illumina
Abbreviations: GH, Glycoside hydrolase
Introduction
Bacillus amyloliquefaciens species have been taxonomic-
ally classified as part of the Bacillus subtilis group.
Members of this group share substantial morphological
similarities and near identical (98.1 %–99.8 %) 16S rRNA
gene sequences [1]. Other members of the Bacillus subtilis
group include B. subtilis, B. atrophaeus, B. licheniformis,
B. sonorensis, B. tequilensis, B. vallismortis, and the B.
mojavensis subgroup. The production of bioactive metab-
olites, the ability to form spores and a lack of pathogen-
icity make members of the Bacillus subtilis group ideal
candidates for use as probiotics. Strains of B. amylolique-
faciens synthesise non-ribosomal bioactive lipopeptides
such as surfactin, fengycin, bacillomycin D and members
of the iturin family [2–4]. These lipopeptides have demon-
strated activity as antimicrobials and inhibit a wide range
of bacterial and fungal pathogens [3, 5].
The strain B. amyloliquefaciens H57 (H57 hereafter)
was first isolated in the search for a biological control
agent to prevent fungal spoilage of hay [6]. Due to its
spore forming ability and production of antimicrobial
compounds, H57 was revealed as the best candidate of a
panel of isolates for commercialisation as a spoilage con-
trol agent under the product name HayRite™. Import-
antly, sheep and cattle fed on HayRite™ treated feed
showed an increase in digestibility and nitrogen reten-
tion leading to increased live weight gain [6]. This new
development into the potential of H57 to act as a pro-
biotic has led to further investigation of this strain.
Here, we present a summary description of the classifi-
cation and features of H57, along with a sequencing de-
scription and annotation summary. The availability of a
genome sequence for H57 will facilitate research into
the probiotic effects observed in animals treated with
this bacterium.
Organism information
Classification and features
A near-complete 16S rRNA gene was identified in the
H57 genome, which by BLAST [7] is most closely related
(99 % identical) to other B. amyloliquefaciens strains in-
cluding FZB42 (B. amyloliquefaciens subsp. plantarum;
acc. NR075005.1), HPCAQB14 (acc. KF861603.1) and SB
3200 (acc. GU191911.1). Comparison of the average read
coverage of the genome and 16S rRNA gene, suggests that
H57 has 13 copies of the rRNA operon. A concatenated
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alignment of 99 single copy marker genes obtained from
publicly available Bacillus genomes using HMMER [8]
confirmed the classification of strain H57 as a member of
the species B. amyloliquefaciens (Fig. 1).
H57 is a Gram-positive rod shaped bacterium averaging
2.5 μm in length and 1 μm in width (Fig. 2d). It is an aer-
obic spore forming bacterium that is motile with peritri-
chous flagella. H57 spores are centrally located and average
1.25 μm in length (Fig. 2b). Optimum growth occurs at a
temperature of 29 °C and pH 7.0 (Table 1). The colony
morphology of strain H57 is circular convex with undulate
margins. When grown on a nutrient agar plate, colonies are
an off-white colour as shown in Fig. 2c.
Genome sequencing information
Genome project history
Strain H57 was selected for sequencing due to its abil-
ity to act as a probiotic in agricultural animals. The
Fig. 1 Maximum likelihood tree showing the alignment of H57 with other Bacillus genomes. Alignment was performed using HMMER [8] whilst
maximum likelihood was inferred using FastTree version 2.7.7 [32]. The inferred tree was visualised using ARB version 6.0.2 [33]. Bar: 0.1
substitutions per nucleotide position
a b
c d
Fig. 2 Cellular and colony morphology of B. amyloliquefaciens H57. a Vegetative H57 cells at 1000x magnification captured with a Nikon DS-Ri1 camera
attached to a Nikon Eclipse 80i microscope under phase contrast. b H57 spores at 1000x magnification captured with a Leica DFC 500 camera attached to
a Leica DM5500B compound microscope with Nomarski differential interference contrast. c Pure culture of H57 grown on nutrient agar plate. d Electron
microscope image of a vegetative H57 cell showing numerous peritrichous flagella, negatively stained with phosphotungstic acid
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draft genome was deposited in GenBank under the ac-
cession number LMUC00000000. Genome sequencing
and assembly was performed at the Australian Centre
for Ecogenomics, The University of Queensland. Gene
annotation was performed using the AnnotateM script
[9]. A summary of the project is shown in Table 2
using MIGS version 2.0 [10] criteria.
Growth conditions and genomic DNA preparation
Genomic DNA of H57 was isolated from a freeze-dried
product of H57 spores combined with sodium bentonite
(1:1). DNA was extracted from the H57 spores using the
‘Repeated Bead-beating and Column Extraction’ method
described by Yu and Forster (2005) [11]. In brief, 0.1 g of
sporulated product was added to 1 mL of lysis buffer
(2.9 % NaCl, 0.6 % Tris, 0.05 M EDTA pH 8.0 and 4 %
SDS) in a cryotube containing 0.5 g zirconia beads (BioS-
pec Products Inc., Bartlesville, USA). The sample was then
homogenised in a mini bead beater 16 (BioSpec Products
Inc., Bartlesville, USA) for 2 cycles of 3 min. Between cy-
cles the samples were incubated for 15 min at 70 °C, cen-
trifuged (13,200 rpm for 5 min at 4 °C) and supernatant
transferred to a fresh tube. Following bead beating further
extraction was performed on the supernatant using the
QIAGEN QIAmp DNA Mini Kit as per kit instructions
(QIAGEN, Doncaster, VIC).
Genome sequencing and assembly
The genome of H57 was sequenced on an Illumina
MiSeq sequencing platform (Illumina, Inc. San Diego,
CA). DNA libraries were prepared using the Nextera®
XT DNA Library Preparation Kit (Illumina, San Diego,
CA) according to the manufacturer’s instructions. An in-
put of 1 ng was used to prepare DNA libraries, which
was then cleaned using Agencourt AMPure XP beads
(Beckman Coulter, Brea, CA, USA). The purified PCR
product was then size selected for amplicons with a size
between 300 bp and 800 bp. Illumina paired-end se-
quencing was performed, producing a total of 1,351,526
reads. Primer and adaptor sequences were removed
Table 1 Classification and general features of Bacillus
amyloliquefaciens strain H57 [10]
MIGS ID Property Term Evidence
codea
Classification Domain Bacteria TAS [34]
Phylum Firmicutes TAS
[35–37]
Class Bacilli TAS
[38, 39]
Order Bacillales TAS
[40, 41]
Family Bacillaceae TAS
[40, 42]
Genus Bacillus TAS [40,
43, 44]
Species Bacillus
amyloliquefaciens
TAS
[45–47]
Strain: H57
Gram stain Positive IDA
Cell shape Rod/chains IDA
Motility Motile IDA
Sporulation Sporulating IDA
Temperature
range
Mesophilic IDA
Optimum
temperature
29 °C IDA
pH range;
Optimum
5-9; 7 IDA
Carbon source Glucose, fructose, mannitol,
sucrose, trehalose
IDA
MIGS-6 Habitat Leaves of Medicago sativa TAS [6]
MIGS-6.3 Salinity Up to 6 % (w/v) IDA
MIGS-22 Oxygen
requirement
Aerobe IDA
MIGS-15 Biotic
relationship
Symbiotic (beneficial) TAS [6]
MIGS-14 Pathogenicity Non-pathogen NAS
MIGS-4 Geographic
location
Gatton, QLD, Australia IDA
MIGS-5 Sample
collection
2001 IDA
MIGS-4.1 Latitude 27° 32' 24'' S IDA
MIGS-4.2 Longitude 152° 20' 24'' E IDA
MIGS-4.4 Altitude 89 m IDA
a Evidence codes - IDA Inferred from Direct Assay, TAS Traceable Author
Statement (i.e., a direct report exists in the literature), NAS Non-traceable
Author Statement (i.e., not directly observed for the living, isolated sample,
but based on a generally accepted property for the species, or anecdotal
evidence). These evidence codes are from the Gene Ontology project [48]
Table 2 Project information
MIGS ID Property Term
MIGS 31 Finishing quality Draft
MIGS 28 Libraries used Illumina paired end library
(256 bp insert size)
MIGS 29 Sequencing platforms Illumina MiSeq
MIGS 31.2 Fold coverage 49×
MIGS 30 Assemblers Spades 3.0.0.
MIGS 32 Gene calling method PROKKA
Locus tag Ga0082361
Genbank ID LMUC00000000
GenBank Date of Release 04/04/2016
GOLD ID Ga0082361
BIOPROJECT PRJNA300579
MIGS 13 Source material identifier Bacillus amyloliquefaciens H57
Project relevance Probiotic, Agriculture
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using Trimmomatic v0.32 [12] resulting in an average
read length of 256 bp. Reads were assembled using
SPAdes 3.0.0. [13]. The H57 genome was obtained in 16
contigs ranging in size from 701,147 bp to 10,158 bp
with a combined length of 3,958,833 bp. Genome com-
pleteness and contamination was estimated using
CheckM version 1.0.0, indicating that the genome was
near complete (99.51 %) with no detectable contamin-
ation (0 %) [14].
Genome annotation
Gene annotation was achieved using a combination of pro-
tein databases via AnnotateM Version 6.0 [9]. Open read-
ing frames were initially generated using PROKKA [15].
The resulting protein sequence was then searched against
the IMG, Uniref, COG, PFAM and TIGRfam databases
[16–20] to identify homologous genes. The software Protei-
nOrtho [21] was used to identify orthologous genes to
other known B. amyloliquefaciens strains for further com-
parison. Genes unique to H57 were compared against the
KEGG gene database [22] to identify metabolic functions.
Genome properties
The draft genome assembly of H57 consists of sixteen
contigs totalling 3,958,833 bp and a G + C content of
46.42 %, which is likely a slight underestimate of its gen-
ome size due to unresolved collapsed repeats, primarily
rRNA operons (Table 3). With a coding region of
3,549,557 bp, this assembly represents a total of 3,945
ORFs. Of those genes, 3,836 encode proteins and the re-
mainder encode sixteen rRNAs (7 × 5S, 7 × 16S and 2 ×
23S), 69 tRNAs and 24 other RNA genes (Table 3). Of
the annotated genes, the majority were assigned a
putative function (80.66 %) with 69.81 % assigned into
Clusters of Orthologous Groups, presented in Table 4.
Of the 3,945 ORFs in the H57 genome, 3,751 were in-
ferred to be orthologous to other B. amyloliquefaciens
strains, including strains CC178, DSM7, XH7, TF28, Y2,
IT-45, LFB112 and B. amyloliquefaciens subsp plan-
tarum strains UCMB5113, FZB42, NAU-B3, YAU
B9601-Y2, and TrigoCor1448. Of the 194 genes unique
to H57, several appear to be involved in the degradation
of aromatic compounds, more specifically the break-
down of 4-hydroxyphenylacetic acid.
Insights from the genome sequence
Comparative analysis of the H57 genome indicates that
its central metabolism is consistent with other strains of
B. amyloliquefaciens. The presence of a complete TCA
cycle and electron transport chain indicates the potential
for aerobic respiration. H57 has a narGHJI operon and
the transcriptional regulator fnr, suggesting that it is also
Table 3 Genome statistics
Attribute Value % of Total
Genome size (bp) 3,958,833 100.00
DNA coding (bp) 3,549,557 89.66
DNA G + C (bp) 1,837,549 46.42
DNA scaffolds 16 100.00
Total genes 3,945 100.00
Protein coding genes 3,836 97.24
RNA genes 109 2.76
Pseudo genes 0 0.00
Genes with internal clusters 387 9.81
Genes with function prediction 3,182 80.66
Genes assigned to COGs 2,754 69.81
Genes with Pfam domains 3,364 85.27
Genes with signal peptides 191 4.84
Genes with transmembrane helices 1,046 26.51
CRISPR repeats 0 0.00
Table 4 Number of genes associated with general COG
functional categories
Code Value %agea Description
J 136 3.48 Translation, ribosomal structure and biogenesis
A 0 0.00 RNA processing and modification
K 89 2.23 Transcription
L 95 2.43 Replication, recombination and repair
B 1 0.03 Chromatin structure and dynamics
D 22 0.56 Cell cycle control, Cell division, chromosome
partitioning
V 17 0.44 Defence mechanisms
T 58 1.48 Signal transduction mechanisms
M 97 2.48 Cell wall/membrane biogenesis
N 40 1.02 Cell motility
U 37 0.95 Intracellular trafficking and secretion
O 64 1.64 Posttranslational modification, protein turnover,
chaperones
C 92 2.35 Energy production and conversion
G 109 2.79 Carbohydrate transport and metabolism
E 160 4.09 Amino acid transport and metabolism
F 62 1.59 Nucleotide transport and metabolism
H 93 2.38 Coenzyme transport and metabolism
I 53 1.36 Lipid transport and metabolism
P 93 2.38 Inorganic ion transport and metabolism
Q 30 0.77 Secondary metabolites biosynthesis, transport
and catabolism
R 203 5.19 General function prediction only
S 238 6.09 Function unknown
- 2169 55.49 Not in COGs
aThe total is based on the total number of protein coding genes in
the genome
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capable of growing anaerobically using nitrate as an elec-
tron acceptor [23]. This capability would be required for
H57 to grow in anoxic environments.
The genome of H57 also encodes a number of en-
zymes involved in carbohydrate metabolism. A search
against the carbohydrate-active enzyme database [24] re-
veals that H57 is dominant in glycoside hydrolase fam-
ilies 1, 43 and 13 (Table 5). The GH 1 and GH 43
families comprise enzymes that degrade the various
sugar monomers of hemicellulose. This suggests that
H57 may contribute to breaking down the less fibrous
components of the plant cell wall. The abundance of GH
13 enzymes, which are a family of α-amylases, suggests
that H57 also contributes to the breakdown of starch.
The presence of these carbohydrate-activated enzymes
alludes to the notion that H57 may assist in the diges-
tion of animal feeds by breaking down certain polysac-
charides of the plant cell wall.
Consistent with observed anti-fungal activity, the H57
genome encodes a broad range of antimicrobial com-
pounds. These include genes for non-ribosomal synthe-
sis of antimicrobial lipopeptides such as surfactin
(srfABCD), iturin (ituABCD), bacillomycin D (bmyABC)
and fengycin (fenABCDE). Surfactin is capable of inhibit-
ing a wide range of microorganisms due to its ability to
insert itself into the cell wall creating ion pores [25].
Bacillomycin D, iturin and fengycin all have demon-
strated antifungal properties primarily based on their
ability to disrupt the fungal cell wall [26–28]. The genes
for the expression of antibiotic polyketides are also
present on the H57 genome. These include the operons
mlnABCDEFGHI, dfnABCDEFGHIJ and baeEDLMNJRS,
which encode macrolactin, difficidin and bacillaene re-
spectively. These compounds inhibit a wide range of mi-
croorganisms acting chiefly on preventing protein
synthesis [29–31].
Conclusions
The ~3.96 Mbp genome of B. amyloliquefaciens H57 re-
veals the basis of its antimicrobial nature and potential
to survive and reproduce in anoxic animal gastrointes-
tinal tracts. In common with other B. amyloliquefaciens
strains, H57 encodes a wide range of antimicrobial com-
pounds that explain its effectiveness as a biocontrol
agent for fungi and other feed spoilage organisms. The
production of these compounds may also contribute to
the observed probiotic effect by inhibiting potentially
pathogenic organisms creating a healthier microbial
ecosystem.
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Table 5 Carbohydrate activated enzyme profile of glycoside
hydrolases in H57
Family Known activity %a
GH16 Xyloglucan, keratan-sulfate, endo-1,4-β-galactosidase,
endo-1,3- β-glucanase, and others
2.5
GH4 Maltose-6-phosphate glucosidase, α-glucosidase,
α-galactosidase, and others
7.5
GH5 Chitosanase, β-mannosidase, cellulase, glucan 1,
3-β-glucosidase, and others
2.5
GH13 α-amylase, pullulanase, cyclomaltodextrin
glucanotransferase and others
10
GH11 Xylanase 2.5
GH23 Lysozyme type G and peptidoglycan lyase 2.5
GH3 β-glucosidase, xylan 1,4-β-xylosidase, β-N-
acetylhexosaminidase, and others
2.5
GH126 Other 2.5
GH18 Chitinase, endo-β-N-acetylglucosaminidase,
and others
7.5
GH26 β-mannanase and β-1,3-xylanase 2.5
GH53 Endo-β-1,4-galactanase 2.5
GH51 α-L-arabinofuranosidase and endoglucanase 5
GH1 β-glucosidase, β-galactosidase, β-mannosidase,
and others
12.5
GH73 Peptidoglycan hydrolase with endo-β-N-acetylglucosami-
nidase specificity
5
GH30 Glucosylceramidase, β-1,6-glucanase, β-xylosidase 5
GH32 Endo-inulinase, endo-levanase, exo-inulinase,
and others
7.5
GH46 Chitosanase 2.5
GH109 α-N-acetylgalactosaminidase 5
GH43 Arabinases and xylosidases 10
GH68 Levansucrase, β-fructofuranosidase
and inulosucrase
2.5
Total GH hits: 40
Total ORFs: 3,828
% GH ORFs: 1.04
aPercentage of total GH hits
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